» Articles » PMID: 10027746

Role of the Kappa-opioid System in the Attenuation of the Morphine-induced Place Preference Under Chronic Pain

Overview
Journal Life Sci
Publisher Elsevier
Date 1999 Feb 23
PMID 10027746
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We previously reported that the morphine-induced place preference was attenuated under inflammation produced by the unilateral injection of 2.5 % formalin (50 microl) into the hind paw of rats. In the present study, to elucidate the mechanism of this attenuation, the effects of pretreatment with delta- and kappa-opioid receptor antagonists, naltrindole (NTI) and nor-binaltorphimine (nor-BNI), on the development of the morphine-induced place preference under inflammation were examined in rats. Nor-BNI, but not NTI, eliminated the suppression of the morphine-induced place preference in inflamed groups. These results suggest that endogenous kappa-opioid systems may be activated in the presence of chronic inflammatory nociception; as a result, the development of morphine's rewarding effect may be suppressed under inflammation.

Citing Articles

The Role of Mesostriatal Dopamine System and Corticostriatal Glutamatergic Transmission in Chronic Pain.

Ziolkowska B Brain Sci. 2021; 11(10).

PMID: 34679376 PMC: 8533867. DOI: 10.3390/brainsci11101311.


Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems.

Wawrzczak-Bargiela A, Ziolkowska B, Piotrowska A, Starnowska-Sokol J, Rojewska E, Mika J Neurotox Res. 2020; 37(4):800-814.

PMID: 32026358 PMC: 7085470. DOI: 10.1007/s12640-020-00166-4.


Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Neelakantan H, Ward S, Walker E Exp Clin Psychopharmacol. 2016; 24(6):485-495.

PMID: 27929349 PMC: 5157702. DOI: 10.1037/pha0000097.


Morphine self-administration following spinal cord injury.

Woller S, Malik J, Aceves M, Hook M J Neurotrauma. 2014; 31(18):1570-83.

PMID: 24827476 PMC: 4161170. DOI: 10.1089/neu.2013.3293.


The application of conditioning paradigms in the measurement of pain.

Li J Eur J Pharmacol. 2013; 716(1-3):158-68.

PMID: 23500202 PMC: 3708987. DOI: 10.1016/j.ejphar.2013.03.002.